|
[1]
|
Does price negotiation in China bring high-value novel drugs to the national medical insurance beneficiaries?
Health Policy and Technology,
2025
DOI:10.1016/j.hlpt.2024.100963
|
|
|
|
|
[2]
|
Population Aging and the Demand for Private Health Insurance in China
Asia-Pacific Journal of Risk and Insurance,
2022
DOI:10.1515/apjri-2019-0042
|
|
|
|
|
[3]
|
The impact of public health education on people's demand for commercial health insurance: Empirical evidence from China
Frontiers in Public Health,
2022
DOI:10.3389/fpubh.2022.1053932
|
|
|
|
|
[4]
|
Population Aging and the Demand for Private Health Insurance in China
Asia-Pacific Journal of Risk and Insurance,
2022
DOI:10.1515/apjri-2019-0042
|
|
|
|
|
[5]
|
Population Aging and the Demand for Private Health Insurance in China
Asia-Pacific Journal of Risk and Insurance,
2022
DOI:10.1515/apjri-2019-0042
|
|
|
|
|
[6]
|
Recent Pricing Negotiations on Innovative Medicines Pilot in China: Experiences, Implications, and Suggestions
Value in Health Regional Issues,
2018
DOI:10.1016/j.vhri.2018.01.009
|
|
|
|
|
[7]
|
Innovative payer engagement strategies: will the convergence lead to better value creation in personalized medicine?
EPMA Journal,
2017
DOI:10.1007/s13167-017-0078-6
|
|
|
|
|
[8]
|
Determinants of Health Insurance Coverage among People Aged 45 and over in China: Who Buys Public, Private and Multiple Insurance
PLOS ONE,
2016
DOI:10.1371/journal.pone.0161774
|
|
|
|
|
[9]
|
Insurance coverage and socioeconomic differences in patient choice between private and public health care providers in China
Social Science & Medicine,
2016
DOI:10.1016/j.socscimed.2016.10.016
|
|
|
|